Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ChiRex (CHRX) -- Ignore unavailable to you. Want to Upgrade?

To: John A. Stoops who wrote (116)	3/19/1999 4:24:00 PM
From: BD	Read Replies (1) \| Respond to of 130

I was very disapointed that someone most likely with the company or underwriters bid stock up last night and screwed the IPO investors with a $19 price, higher than they could have bought it for in the open market for the last week plus. I also got what I asked for (#of shares)which worrys me also (typically its a percentage of). However my experience with secondarys indicates that new awareness, assets and underwriter investment almost always pushes issue higher. Frankly I do read prospectus's before chomping (unless the compaany has ".com" or "net" in the name :>) and found ChiRex to be a very exciting bio-tech investment. I would have been happy to buy it at 17.5 all day yesterday and thought that the IPO would price 16-17, so was very upset at the last hour manipulation. However now that I am an owner, the fact they didn't offer anymore than 2.5 Million shares is very comforting, they easily could have. The extra cash raised will always help us in the long run.